HME News18h
Glucotrack completes first human clinical study for CBGM
Glucotrack has successfully completed its first in-human clinical study for the first real-time, continuous blood glucose monitor (CBGM) placed in the subclavian vein.
Are smartphone diabetes devices putting lives in danger? US FDA sounds alarm
The US FDA warns users of smartphone-linked diabetes devices like CGMs and insulin pumps of potential health risks due to ...
Patients using diabetes apps can miss critical alerts. Here’s how to make sure you’re getting them
These days, many devices are programmed through apps on patients’ phones. But the FDA warns that certain phone settings, such ...
Gonzagabulletin.com1d
A look into the future: How technology has aided glucose monitoring
Gonzaga University and the UW School of Medicine hosted Irl Hirsch to lecture about the future of glucose monitoring.
Senseonics Completes CE Mark Submission for Eversense 365, World’s Longest-lasting Continuous Glucose Monitor
Eversense 365 is the world’s first and only one year CGM, which was approved by the United States (US) Food and Drug Administration in September of 2024 and launched across the country in October of ...
Semiconductor Engineering1d
Med Tech Morphs Into Consumer Wearables
Smart watches, rings, and a growing array of patches are adding more functionality and being used across a growing set of ...